Twin Tree Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-106,236
Closed -$11.2M 1297
2022
Q2
$11.2M Buy
106,236
+104,414
+5,731% +$13.3M 0.02% 611
2022
Q1
$314K Buy
+1,822
New +$272K ﹤0.01% 1427
2020
Q3
Sell
-3,245
Closed -$644K 1200
2020
Q2
$644K Buy
+3,245
New +$605K ﹤0.01% 1121

Other funds holding AMED

Twin Tree Management's AMED Position: Q3 2022 in Review

Twin Tree Management sold out of Amedisys (AMED) in Q3 2022, closing a stake of 106,236 shares — an estimated $11.2M sold.

Twin Tree Management first reported a position in AMED in Q2 2020 and held it in 3 quarters. The position peaked at $11.2M in Q2 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • Twin Tree Management reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
  • Twin Tree Management sold 106,236 Amedisys shares in Q3 2022, an estimated $11.2M.
  • Twin Tree Management first reported a position in Amedisys in Q2 2020 and held it in 3 quarters.
  • Twin Tree Management's Amedisys position peaked at $11.2M in Q2 2022.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Twin Tree Management's 13F filing for Q3 2022, filed 10 Nov 2022.